Sitagliptin

Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes

Doxycycline in Type II Diabetes

Sitagliptin or BeiDouGen Capsule Improve the Pregnancy Outcome in Patients with PCOS

DM Treatment to Evaluate the Efficacy and Safety of Dapagliflozin or Pioglitazone in Patients with Type 2 Diabetes

A Phase IV Clinical Trial to Compare the Efficacy and Safety of Metformin+Sodium-Glucose Cotransporter 2 Inhibitor(SGLT2-i)+Thiazolidinedione (TZD) in Patients With Type 2 Diabetes

A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas

Triple Hypoglycemic Regimens In Patients With Newly Diagnosed Type 2 Diabetes Mellitus

Sitagliptin in Recurrent/Progressive Grade 4 Glioma

Sitagliptin With Pembro in RCC and Melanoma

Efficacy and Safety of Canagliflozin in the Treatment of Type 2 Diabetes With Mild Cognitive Impairment

Sun Yat-Sen Treatment Strategy for Enhancing Response in Muscle-invasive Bladder Cancer

Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus

Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED)

Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021)

An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (MK0431-023)

An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (0431-024)

An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED)

MK0431 (Sitagliptin) and Metformin Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-036)

Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035)

A Study of an Investigational Drug Sitagliptin for Type 2 Diabetes Mellitus (0431-044)

MK0431 Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-040)

Study of Sitagliptin in Older Type 2 Diabetics (0431-047)(COMPLETED)

Sitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus

Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052)

Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus

Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus

Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus

Incretins in Impaired Fasting Glucose

MK-0431 Early Phase II Double-blind Study - Type 2 Diabetes Mellitus (0431-043)

MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED)

Sitagliptin Added-on to Insulin Study (0431-051)

Initial Combination With Pioglitazone Study (0431-064)

Long Term Effects of DPP-IV Inhibitor Treatment in Patients With Type 2 Diabetes

A Study of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet/Exercise Therapy (0431-054)(COMPLETED)

A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008)

Beta-Cell Function and Sitagliptin Trial (BEST)

Effect of Januvia on Beta Cell Function in Patients With Diabetes Mellitus

Sitagliptin Comparative Study in Patients With Type 2 Diabetes (0431-049)

Sitagliptin in the Elderly

Sitagliptin Treatment in Patients With Type 2 DM After Kidney Transplant

A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus

A Study of Different Doses of Sitagliptin (MK-0431) in Participants With Type 2 Diabetes Mellitus (MK-0431-014)

A Study of MK0431 in Patients With Type 2 Diabetes (0431-010)

MK0431A Comparative Study in Patients With Type 2 Diabetes (0431A-079)(COMPLETED)

Effects of Colesevelam HCl, Rosiglitazone, Sitagliptin on Control of Blood Glucose and Lipids in Type 2 Diabetes Patients Whose Blood Glucose Isn't Completely Controlled With Metformin

Effects of Sitagliptin on Gastric Emptying in Healthy Subjects

Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1)

Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1)

Sitagliptin and Pioglitazone Mechanism of Action Study in Type 2 Diabetes Mellitus (0431-061)

MK0431A vs. Pioglitazone in Patients With Type 2 Diabetes Mellitus (0431A-066)

Sitagliptin Dose Comparison Study in Patients With Type 2 Diabetes (MK-0431-077)(COMPLETED)

A Study to Evaluate the Efficacy and Safety of Sitagliptin and MK0431A in Comparison to a Commonly Used Medication in Patients With Type 2 Diabetes (0431-068)(COMPLETED)

Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801)

Addition Of Januvia (Sitagliptin) Improves Glycemic Control In Patients Inadequately Controlled By Metformin (MK0431-078)

Effect of Sitagliptin on Incretin Effect in Patients With Type 2 Diabetes Mellitus

Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency

Beta-cell Function in Glucose Abnormalities and Acute Myocardial Infarction

A Study to Test the Effectiveness and Safety of MK0893 in Combination With Other Drugs Used to Treat Type 2 Diabetes (0893-015)

A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)

An Efficacy, Safety, and Tolerability Study of Canagliflozin (JNJ-28431754) in Patients With Type 2 Diabetes

An Open-Label, Single- & Multiple-Dose Study to Investigate the Pharmacokinetics of Sitagliptin 100 mg in Healthy Chinese Adult Subjects (0431-108)(COMPLETED)

Sitagliptin Plus Granulocyte-colony Stimulating Factor in Acute Myocardial Infarction

Study of the Effect of Sitagliptin on Glucose (Sugar) Metabolism in Patients With Heart Failure

The Effect of Januvia (Sitagliptin) on Oxidative Stress in Obese Type 2 Diabetic Subjects

Effects of Sitagliptin on Postprandial Lipemia in Men With Type 2 Diabetes

18-week add-on to Metformin Comparison of Saxagliptin and Sitagliptin in Adult Patients With Type 2 Diabetes (T2D)

Effect of Sitagliptin and an ACE Inhibitor on Blood Pressure in Metabolic Syndrome

Effects of Glutamine on GLP-1 and Insulin Secretion in Man

Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)

Quantification of the Dipeptidyl Peptidase (DPP)-4 Inhibition-mediated Enhancement of the Activity of the Entero-insular Axis

A Double-Blind, Randomized, Active-Comparator (Metformin) Controlled, Clinical Trial to Study the Efficacy and Safety of the Strategy to Start Patients With Type 2 Diabetes Mellitus on Janumet™ Compared to Metformin

Sitagliptin in Combination With Metformin and Sulfonylurea

A Study of MK0431 in Patients WIth Hepatic Insufficiency (0431-017)(COMPLETED)

The Effect of Sitagliptin on Hypertension, Arterial Stiffness, Oxidative Stress and Inflammation

Effect of Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability and Oxidative Stress

The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus

A Study to Test the Safety and Efficacy of Sitagliptin Compared to Glimepiride in Patients With Type 2 Diabetes on a Stable Dose of Metformin (0431-803)(COMPLETED)

Sitagliptin Mechanism of Action Study in Patients With Type 2 Diabetes Mellitus (0431-059)

The Effect of Linagliptin (BI 1356) on 24h-glucose Control and Various Biomarkers in Type 2 Diabetic Patients

Sitagliptin Prophylaxis for Glucocorticoid-Induced Impairment of Glucose Metabolism in Males With the Metabolic Syndrome

MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2)

Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a Thiazolidinedione

A Study to Assess the Pharmacokinetics, Safety and Tolerability of Sitagliptin in Adolescents (0431-081)

Bone Turnover in Type 2 Diabetes Patients

A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin

Sitagliptin in Renal Transplant Recipients

How Improvement in Control of Diabetes Influences the Production of a Hormone Produced in the Gut Which Improves the Release and Action of Insulin.

BI 10773 add-on to Metformin in Patients With Type 2 Diabetes

Evaluation of Insulin Glargine Versus Sitagliptin in Insulin-naive Patients

A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.

Clinical Study on Sitagliptin for Assessment of Glucose-lowering Effects (0431-045)

Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes Mellitus

Sitagliptin Versus Sulphonylurea in Type 2 Diabetes During Ramadan

Incretin Effect and Use After Clinical Islet Transplantation

Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study)

Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass

Response To Oral Agents in Diabetes (ROAD)- Pilot Study

Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 Diabetes

Sitagliptin Cardiovascular Outcomes Study (MK-0431-082)

Effect of Januvia on Ghrelin and Other Gut Hormones in Patients With Diabetes

Incretin Effect in People With Impaired Fasting Glucose

Use of Continuous Glucose Monitoring Combined With Ambulatory Glucose Profiles to Characterize Glycemic Control

Assessment of the Effects of a DPP-4 Inhibitor (Sitagliptin) Januvia on Immune Function in Healthy Individuals

A Study to Test the Safety and Efficacy of Adding Sitagliptin in Patients With Type 2 Diabetes Mellitus (MK0431-074)

Mechanisms of Glucose Lowering Effects of Sitagliptin and Metformin Alone and in Combination in Patients With T2DM

A Study of the Effects of Co-Administration of Sitagliptin (MK-0431) and Metformin on Incretin Hormone Concentrations (MK-0431-110)

Study to Assess the Efficacy and Safety of Sitagliptin in Recently Diagnosed, Naive Type 2 Diabetics With Inadequate Glycemic Control on Diet and Exercise (0431-158)

The Effect of Sitagliptin in Type 2 Diabetes Mellitus With Inadequate Glycemic Control (MK0431-118)

ALPHA Sitagliptin Add on to Metformin (0431-103)

MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus (MK0431-104)

Novel Therapy to Preserve Beta Cell Function in New Onset Type 1 Diabetes

Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes

A Drug Interaction Study of VI-0521 With Metformin, Sitagliptan and Probenecid in Healthy Subjects.

Pharmacokinetic Drug Interaction Study of Dapagliflozin and Glimepiride or Sitagliptin in Healthy Subjects

Treatment With Sitagliptin for Reactive Hypoglycemia Secondary to Dysinsulinism

Evaluation of Insulin Glargine in Combination With Sitagliptin in Type 2 Diabetes Patients: EASIE Extension Trial

Effect of Sitagliptin on Graft Function Following Islet Transplantation

MK-0431/ONO-5435 Phase III Clinical Trial - Insulin Add-on Study for Patients With Type 2 Diabetes Mellitus

Evaluation of the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type 2 Diabetes

Efficacy and Long-Term Safety of Vildagliptin as Add-on Therapy to Metformin in Patients With Type 2 Diabetes

Sitagliptin Umbilical Cord Blood Transplant Study

A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (Explores What the Body Does to the Drug), and Pharmacodynamics (Explores What a Drug Does to the Body) of JNJ-38431055 in Volunteers With Type 2 Diabetes Mellitus

Study to Assess the Efficacy and Safety of Sitagliptin Added to the Regimen of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (0431-189)

Empagliflozin (BI 10773) in Type Two Diabetes (T2D) Patients, Open Label Extension

"Effect of Dipeptidyl Peptidase IV After Diets in näive Type 2 Diabetic Patients"

Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128)

Effects of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Hormonal Responses to Macronutrient Ingestion

A Method to Evaluate Glucose-Dependent Insulin Secretion in Healthy Males (MK-0431-179)

Sitagliptin/Metformin Fed Bioequivalence Study (0431A-080)

Using Sitagliptin as a Treatment to Prevent New Onset Diabetes After Kidney Transplantation

Effect of Sitagliptin on Postprandial Lipoprotein Metabolism

Study of the Bioequivalence of Two Tablet Forms of MK0431 (0431-027)

Dipeptidyl Peptidase-4 Inhibition on Glucagon-like Peptide-1 (GLP-1)

Effectiveness and Safety of Two Approaches to the Management of Type 2 Diabetes Mellitus in Australian Primary Care

Superiority of Glimepiride Over Sitagliptin in Naive Type 2 Diabetes Patients

Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal Impairment

Clinical Trial to Investigate the Pharmacokinetics/Pharmacodynamics of Sitagliptin

Effect of Sitagliptin in Impaired Glucose Tolerance

A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Co-administration of Sitagliptin and Metformin as Individual Tablets (0431A-095)

A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Concomitant Administration of Sitagliptin and Metformin as Individual Tablets (0431A-048)

Phenotypic and Genetic Correlates of Diabetes (Non-Type 1) in Young Non-Obese Asian Indians in North India and A Study to Evaluate the Efficacy of Sitagliptin (DPP-4 Inhibitor) in a Sub-group of the Study Population

Prevention of Cystic Fibrosis Diabetes

Effect of Sitagliptin on Endothelial Progenitor Cells

Predictive Parameters for Efficacy of Sitagliptin and Metformin Combination

Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetes

A Study of the Effects of Sitagliptin (MK0431) and Metformin on Incretin Hormone Concentrations (0431-050)(COMPLETED)

A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes

24-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 Years

Assessing Glucose Effects of Sitagliptin (Januvia) in Adult Patients With Type 1 Diabetes

Dapagliflozin DPPIV Inhibitor add-on Study

Efficacy and Safety of Sitagliptin/Metformin Fixed-Dose Combination (FDC) Compared to Glimepiride in Participants With Type 2 Diabetes Mellitus (MK-0431A-202)

Safety and Efficacy Study of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin

DPP-4 Inhibition and TZD for DM Prevention

30-Week Extension to an Initial Combination Study (24 Weeks in Duration) of Sitagliptin With Pioglitazone (0431-064)

Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of MBX-2982 Administered Daily for 4 Weeks as Monotherapy in Patients With Type 2 Diabetes

Sitagliptin in Prevention of Type 2 Diabetes Mellitus

Comparison of NN1250 With Sitagliptin in Subjects With Type 2 Diabetes Never Treated With Insulin

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Doses of JNJ-38431055, Sitagliptin, and Co-administration of JNJ-38431055 and Sitagliptin

Januvia Re-examination Study (MK-0431-181)

Sitagliptin/Metformin (JANUMET) Re-examination Study (0431A-182)

Role of Interleukin-6 in Exercise

A Study to Evaluate the Safety and Efficacy of Sitagliptin 100 mg in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (MK-0431-229)

Safety and Efficacy of Co-Administration of Sitagliptin and Metformin in China (MK-0431-121)

A Retrospective Cohort Study of Acute Pancreatitis in Relation to Use of Exenatide and Other Antidiabetic Agents

The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) Trial

Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone

The Effects of Co-admin of Colesevelam and Sitagliptin on Glucose Metabolism in Subjects With Type 2 Diabetes Mellitus

Dipeptidyl Peptidase-4 Inhibition and Immune Function in HIV

Bioequivalence Study of Sitagliptin/Metformin Combination Tablet (MK0431A-122)

Investigate the Effect of AZD1656 on the Pharmacokinetics of Sitagliptin in Patients With Type 2 Diabetes Mellitus

Vascular Effects of Sitagliptin in Diabetes Mellitus

A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.

Ketosis-Prone Diabetes Mellitus (KPDM): Metformin Versus Sitagliptin Treatment

Sitagliptin Versus Insulin Dose Increase in Type 2 Diabetes on Insulin Treatment

A Study to Characterize the Effect on the Pharmacokinetics of ASP1941 and Sitagliptin When Given Together to Healthy Subjects

The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial)

The CANTATA-MP Trial (CANagliflozin Treatment and Trial Analysis - Metformin and Pioglitazone)

The Role of P-glycoprotein in Sitagliptin Clinical Pharmacology

A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics

A Study in Type 2 Diabetic Subjects on Stable Metformin Therapy to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administering Single and Multiple Oral Doses of GSK1292263

Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263)

The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial)

Treatment of Latent Autoimmune Diabetes of the Adult

Combination Therapy With Sitagliptin and Lansoprazole to Restore Pancreatic Beta Cell Function in Recent-Onset Type 1 Diabetes

Protective Effects of Sitagliptin on β Cell Function in Patients With Adult-onset Latent Autoimmune Diabetes (LADA)

Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (MK-0431-130)

Efficacy and Safety of Empagliflozin (BI 10773) Versus Placebo and Sitagliptin Over 24 Weeks in Patients With Type 2 Diabetes

START-J: SiTAgliptin in eldeRly Trial in Japan

Sitagliptin Therapy to Improve Outcomes After Islet Autotransplant

Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251)

Glycemic Holter Study (Continuous Glucose Monitoring) -

Adding Sitagliptin or Pioglitazone to Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin and Sulfonylurea

Comparison Between GLP 1 Analogues and DPP 4 Inhibitors in Type 1 Diabetes Mellitus

A Study to Assess the Safety and Efficacy of ASP1941 in Combination With Dipeptidyl Peptidase-4 (DPP-4) Inhibitor in Type 2 Diabetic Patients

Sitagliptin in Cystic Fibrosis-Related Diabetes

Sitagliptin for the Treatment of Non-alcoholic Steatohepatitis in Patients With Type 2 Diabetes

JanUmet Before Insulin Lantus In Eastern Population Evaluation Program (JUBILEE) In Type 2 Diabetic Patients

Dipeptidyl Peptidase-4 Inhibitors and Alpha-cell Recovery

Evaluation of Low Blood Sugar Events in Participants With Diabetes (MK-0431-402)

Evaluation of Low Blood Sugar Events in Participants With Diabetes (MK-0431-401)

Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in Patients With Type 2 Diabetes

Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)

Effectiveness of Sitagliptin in Glycemic Control in Real World

Prescription Patterns, Resource Utilization & Costs - Add-on Therapy With Anti Dipeptidyl Peptidase-IVs vs Rosiglitazone

Sitagliptin and Kinetics of Triglyceride-rich Lipoproteins Apolipoprotein B48 and B100 in Patients With Type 2 Diabetes

Metformin and Sitagliptin in Women With Previous Gestational Diabetes

Study Of Safety And Efficacy Of PF-04991532 In Subjects With Type 2 Diabetes Mellitus

Efficacy and Safety of Ursodeoxycholic Acid (UDCA) Added to the DPP-4 Inhibitor in People With Type 2 Diabetes and Chronic Liver Diseases

Study of Safety and Efficacy of PF-04991532 in Subjects With Type 2 Diabetes

Study to Compare Sitagliptin Versus Sulfonylurea Treatment During Ramadan Fasting in Patients With Type 2 Diabetes (MK-0431-262)

Effects of Sitagliptin on Type 2 Diabetes Mellitus Patients on Treatment With Metformin and Insulin

Genetic Variation in the Transporters and Hypoglycemic Agents

Pathophysiological Implications of the Incretin Hormones in Maturity Onset of Diabetes of the Young (MODY)

Effect of Treatment With Metformin in Type 2 Diabetes Patients on Alternative Genes Splicing

A Post Marketing Safety Study of Sitagliptin (JANUVIA®) (MK-0431-234)

An Observational Study of Type II Diabetics Treated With Dual Therapy With or Without Sitagliptin (Januvia®/Xelevia®, MK-0431-201)

A Post Marketing Safety Study of Sitagliptin Phosphate/Metformin Hydrochloride (JANUMET®) (MK-0431A-235)

Changes in Bone Turnover With Increased Incretin Hormone Exposure

A Study of GSK256073 in Subjects With Type 2 Diabetes Mellitus Who Are Being Treated With Metformin

Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 Diabetes

Vildagliptin Versus Sitagliptin - Differences in Fasting Plasma Glucose Lowering Efficacy

Dose Response Finding Study of MK-0431/ONO-5435 in Japanese Subjects With Impaired Glucose Tolerance (MK-0431-105)

A Study of LY2189265 and Sitagliptin in Participants With Type 2 Diabetes

A Study of the Current Medical Practice and Outcomes in the Treatment of Type 2 Diabetes Mellitus in an Office Setting (MK-0431-199)

Pharmacogenetics of Ace Inhibitor-Associated Angioedema

Efficacy and Safety of TAK-875 in Combination With Sitagliptin in Participants With Type 2 Diabetes Mellitus

Pharmacodynamics of Mitiglinide/Sitagliptin Compared to Mitiglinide and Sitagliptin

A Study to Evaluate the Pharmacodynamic Effects of Single-Dose Co-Administration of LX4211 With Januvia® in Type 2 Diabetics

Pharmacokinetics Study of Dipeptidyl Peptidase 4 Inhibitor to Control Type 2 Diabetes Mellitus

A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes

A Study to Evaluate ITCA 650 Compared to Sitagliptin for the Treatment of Type 2 Diabetes

Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260)

Effects of Different Early Intensive Therapies on Long-term β-cell Function

Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 Diabetes

A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211)

Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083)

Effect of Sitagliptin on Short-Term Metabolic Dysregulation of Oral Glucocorticoid Therapy

Study to Evaluate the Efficacy of Acarbose,Metformin,Sitagliptin Combination Treatment in DM Patients

Treatment of Diabetes After Gastric Bypass With Sitagliptin

MK-0431/ONO-5435 Phase III Clinical Trial-Rapid-acting Insulin Secretagogue Add-on Study in Patients With Type 2 Diabetes

Treatment Intensification With Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Inadequately Controlled on Sitagliptin and Metformin

Efficacy and Safety of CWP-0403 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin Alone

Sitagliptin Dose Determination Study

Effect of DPP-IV Inhibitor on Glycemic Control and Autonomic Neuropathy in Adult Patients With Diabetes Mellitus

Metformin Add-on Regimen Comparison Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431A-136)

Comparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes

A Study to Assess the Pharmacokinetics and the Ability for Pediatric Participants With Type 2 Diabetes to Swallow MK-0431A XR Tablets (MK-0431A-296)

A Pilot Study Evaluating Safety of Sitagliptin Combined With Peg-IFN Alfa-2a + Ribavirin in Chronic Hepatitis C Patients

A Study Comparing the Pharmacokinetic and Pharmacodynamic Profiles for Sitagliptin, Saxagliptin and Vildagliptin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-142)

DPP-IV Inhibitors Underlying Mechanism of Cancer in Diabetic Patients

A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Sulfonylurea With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-253)

A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Insulin With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-254)

Sitagliptin Regulation of Intestinal and Hepatic Lipoprotein Particle and Hepatic Glucose Production in Humans

Phase III Trial to Evaluate the Efficacy and Safety of LC15-0444 Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes

Contribution of Pancreatic αcells Function to Blood Glucose Regulation in Chinese Type 2 Diabetics- the Effect of Sitagliptin on Glucagon Secretion, Insulin Secretion and Insulin Resistance in Chinese Type 2 Diabetics

Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763

Comparison of Hypoglycaemic Regimens During Ramadan Fasting in Type 2 Diabetes

Treatment With Sitagliptin in Non-obese Japanese Patients With Type 2 Diabetes Mellitus

Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus

Study of Comparing the Different Effect of DPP-4 Inhibitors and Sulfonylurea by Using "Biphase-Hyperglycemic Clamp"

A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-266)

Vildagliptin vs Sitagliptin add-on to Insulin - Impact on Glycemic Profile and Correlation of Hypoglycemic Episodes and Heart Function

Effect of DPP4 Inhibition on Growth Hormone Secretion

A Study to Assess the Safety and Tolerability of Sitagliptin/Simvastatin Fixed-dose Combination (FDC) in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-312)

Omarigliptin (MK-3102) Clinical Trial - Placebo- and Sitagliptin-Controlled Monotherapy Study in Japanese Patients With Type 2 Diabetes Mellitus (MK-3102-020)

Efficacy and Safety Comparative Study of Sitagliptin,Vildagliptin and Saxagliptin

A Study of the Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose When Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313)

ß-Cell Function and Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients With Moderate Hyperglycemia

A Pilot Study to Assess the Glucose Lowering Effect of Metformin and Sitagliptin in Adolescents With Type 1 Diabetes

Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant

Treatment of Dysglycemia Using Sitagliptin in Adolescents With Cystic Fibrosis

SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies

Glucose Variability With DPP-4 Inhibition

A Pooled Analysis of the Safety and Efficacy of MK-0431A and MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Therapy (Alone or in Combination With Insulin) (MK-0431A-170/MK-0431A-289)

Glucagon-like Peptide (GLP) Utilization and Safety

Differences in Endothelial Function Amongst Sitagliptin and Liraglutide Users

A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes

Effects of Lansoprazole on Sitagliptin Glucose-lowering Ability in Healthy Males: a Randomised Crossover Study

Dose-finding Study of LIK066 Compared With Placebo or Sitagliptin to Evaluate Change in HbA1c in Patients With Diabetes

TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes

Comparison of Fasiglifam (TAK-875) With Sitagliptin When Used in Combination With Metformin in Patients With Type 2 Diabetes

Study to Evaluate the Safety and Efficacy of the Addition of Omarigliptin (MK-3102) Compared With the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-026)

Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes

MASTERMIND - Understanding Individual Variation in Treatment Response in Type 2 Diabetes

Safety and Efficacy of Sitagliptin Added to Insulin Therapy for Type 2 Diabetes

Sitagliptin + Metformin Compared to Metformin Monotherapy and Placebo in Women With a Recent GDM

Effects of Sitagliptin on Endothelial Function in Type 2 Diabetes on Background Metformin Therapy

Sitagliptin Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery Disease

Effect of Chronic Incretin-based Therapy in Cystic Fibrosis

Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study)

Triple Therapy in Type 2 Diabetic Patients

Effect of the DPP-4 Inhibitor Sitagliptin on Islet Function After Mixed Meal in Patients With Type 2 Diabetes

Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin

Efficacy Study of Sitagliptin to Prevent New-onset Diabetes After Kidney Transplant

Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 Diabetes

Study Of Two Dosing Regimens Of PF-04937319 Compared To An Approved Agent (Sitagliptin) In Patients With Type 2 Diabetes

A Study to Investigate the Glucose Lowering Effects of Dextromethorphan Alone or in Combination With Sitagliptin in Subjects With Type 2 Diabetes Mellitus (T2DM) After an Oral Glucose Tolerance Test

Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2D

forREAL: FORXIGA PRESCRIPTION EVENT MONITORING PROGRAM (PEMP)

Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes

Sitagliptin Versus Placebo in the Treatment of Non-alcoholic Fatty Liver Disease

A Study of the Effectiveness and Safety of SP2086 to Treat Type 2 Diabetes

Use of Sitagliptin for Stress Hyperglycemia or Mild Diabetes Following Cardiac Surgery

Prevention and Treatment Of Diabetes Complications With Gastric Surgery or Intensive Medicines

Efficacy and Safety of Empagliflozin Versus Sitagliptin in Patients With Type 2 Diabetes

Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.

Ertugliflozin vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)

The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes

Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers

A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin

Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006; VERTIS SITA2)

Roux-en-Y Gastric Bypass for BMI 27-32 Type 2 Diabetes Versus Best Medical Treatment

Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)

Use of Sitagliptin to Decrease Microalbuminuria

Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly

A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)

DPP-4 Inhibition, Incretins and Islet Function

Ertugliflozin and Sitagliptin Co-administration Factorial Study (VERTIS FACTORAL, MK-8835-005)

A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus

The Effect of Dipeptidyl Peptidase 4 Inhibition on Growth Hormone Secretion in Women With Polycystic Ovarian Syndrome

Effects of Exercise and Inhibition of Dipeptidyl Peptidase-4 on Insulin Secretion in Subjects With Type 1 Diabetes

Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure

Oral and Non-insulin Injected Hypoglycemic Therapy Utilization Patterns

Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects

Bioavailability of BI 10773 and Sitagliptin in Healthy Male Volunteers

Study of Chiglitazar Compare With Sitagliptin in Type 2 Diabetes Patients

Therapeutic Efficacy of Triple Combination in Drug-naïve Korean Type 2 Diabetic Patients

Correlation Between Plasma- and Endothelial DPP-4 Activity

Effect of Lixisenatide on Postprandial Plasma Glucose Compared to Sitagliptin in Combination With Insulin Glargine

A Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 Administered With Metformin to Type 2 Diabetes Patients

Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017)

Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.

Metformin and Sitagliptin Therapy for Adult Patients With Type 2 Diabetes Admitted to the General Medical Unit

A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly Versus Sitagliptin Once Daily in Japanese Subjects With Type 2 Diabetes

Sitagliptin and Glucagon Counterregulation

Evaluation of the DPP-4 Inhibitor Sitagliptin in the Treatment of Non-Alcoholic Fatty Liver Disease Using MRI

Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone

Sitagliptin and Brown Adipose Tissue

Effects of Sitaglpitin on Endothelial Function During the OGTT in T2DM

Dietary Impacts on Glucose-lowering Effects of Sitagliptin in Type 2 Diabetes

DPP-4 Inhibitor and Serum BNP Level of Diabetic Patients With Congestive Heart Failure

Comparison of Lobeglitazone With Pioglitazone as Initial Triple Therapy for Diabetes Management

Efficacy of Sitagliptin and Glibenclamide on the Glucose Variability in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431-355)

Effects of Sitagliptin on Gastric Emptying, Glycaemia and Blood Pressure in Type 2 Diabetes

Randomized Trial Comparing Sitagliptin to Placebo in Closed Loop

Randomized Evaluation of Anagliptin Versus Sitagliptin On Low-density lipoproteiN Cholesterol in Diabetes Trial

Effect of Intact GLP-1 (7-36) and GLP-1 Metabolite (9-36) on Coronary and Peripheral Vascular Function in Adults

Influence of Gut Hormones on Food Intake After Roux-en-Y Gastric Bypass Surgery

Triple Combination Therapy in Type 2 Diabetic Patients Who Had Inadequate Glycemic Control With Combination Therapy

Dipeptidyl Peptidase-4 Inhibition and Narrow-band Ultraviolet-B Light in Psoriasis (DINUP)

The Role of Phosphodiesterase Inhibitors in Incretin Secretion

Fatty Liver Study in Patients With Type II Diabetes

Role of Endoplasmic Reticulum Stress in the Pathophysiology of Type 2 Diabetes

Risk of Nocturnal Hypoglycemia and Arrhythmias With Sitagliptin Versus Glimepiride in Patients With Type 2 Diabetes

DPP-4 Inhibitors and Acute Myocardial Infarction:Effects on Platelet Function

Study on Exploring the Effect of DPP-4 Inhibitors on β-cell Function by Using the Two-step Hyperglycemic Clamp

Add Glucokinase Activator to Target A1c

The INDORSE Study: Inhibition of Dipeptidyl Peptidase IV: Outcomes on Renal Sodium Excretion

Sitagliptin and Endothelial Dysfunction

Sitagliptin in Non-Diabetic Patients Undergoing Cardiac Surgery

Dynamic Responsiveness of Insulin Secretory Parameters To Sitagliptin and Glimeperide Administration in Type 2 DM

Effects of DPP-4 Inhibition on Calcium and Bone Metabolism in Type 2 Diabetes Mellitus

A Study to Assess the Efficacy and Safety of ASP1941 in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin

Incretin-based Drugs and the Risk of Heart Failure

Incretin-based Drugs and Pancreatic Cancer

Incretin-based Drugs and Acute Pancreatitis

Efficacy and Safety of Lobeglitazone Versus Sitagliptin

Degradation of the Anorexic Hormone Peptide YY

Exploratory Study to Compare the Effects of Tenelia® or Januvia® on Glucose Variability in add-on to Metformin (CGMS Study)

Sitagliptin for Reducing Inflammation and Immune Activation

Treatment of Hypoglycemia Following Gastric Bypass Surgery

Metabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) Inhibitors

A Study to Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838)

Sitagliptin Therapy and Kinetics of Inflammatory Markers

Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery

Ipragliflozin Add-on Long-term Study in Japanese Participants With Type 2 Diabetes Mellitus on Sitagliptin (MK-0431J-849)

Tenelia Triple Combination Study

Sitagliptin Effects on Arterial Vasculature and Inflammation in Obesity

Double-blind Ipragliflozin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Sitagliptin (MK-0431J-843)

Double-blind Sitagliptin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Ipragliflozin (MK-0431J-842)

Sitagliptin (DPP-4 Inhibitor) and NPH Insulin in Patients With T2D

Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes

Effect of Dapagliflozin on Vascular Functions in Patients With Type 2 Diabetes Compared to Gliclazide

Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Sitagliptin (REMIT-Sita)

A Phase 2 Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)

Effect of DPP4 Inhibition on Vasoconstriction

12-Week Study of DS-8500a in Subjects With Type 2 Diabetes Mellitus on Metformin

A Pilot Study to Evaluate the Safety of a 3 Weeks Sitagliptin Treatment in HCC Patients Undergoing Liver Resection

The Use of DPP-4 Inhibitors in Short Bowel Syndrome

TriMaster: Study of a DPP4 Inhibitor, SGLT2 Inhibitor and Thiazolidinedione as Third Line Therapy in Patients With Type 2 Diabetes.

Effect of Sitagliptin on Progression of Coronary Intermediate Lesion

Accelerated Wound Healing in Diabetic Ulcers by Sitagliptin

DPP4 Inhibition & Beta Cell Function

Sitagliptin for Prevention of Acute Graft Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

A Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus Receiving Sitagliptin

Evogliptin in Type 2 Diabetes Mellitus (EVOLUTION: EVOgLiptina no Diabetes Mellitus TIpO 2)

Mechanisms Underlying Predictors of Success From Obesity Surgery

Randomized Sitagliptin Withdrawal Study (MK-0431-845)

Sitagliptin in Non-Diabetic Patients Undergoing General Surgery

Drug Transporter Interaction Study PHENTRA_2015_KPUK

Feed-Back Suppression of Meal-Induced Glucagon-like Peptide 1 (GLP-1) Secretion

A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)

The Effect of DPP4 Inhibitor on Vasclular Healing

CKD-396 Drug-drug Interaction Study(A) (CKD-396 DDI(A) P1)

CKD-396 Drug-drug Interaction Study(B) (CKD-396 DDI(B) P1)

Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus.

HbA1c Variability in Type II Diabetes

Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy

Evaluation of the Effect of Sitagliptin on Gut Microbiota in Patients With Newly Diagnosed Type 2 Diabetes

Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure

Treatment of Diabetes in Patients With Systolic Heart Failure

GLP-1 Signaling in Truncally Vagotomized Subjects

Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss

Effectiveness & Tolerability of Novel, Initial Triple Combination Therapy vs Conventional Therapy in Type 2 Diabetes

Efficacy and Safety of Evogliptin add-on to Metformin in Patients With type2 Diabetes

Interaction of Bexagliflozin With Metformin, Glimepiride and Sitagliptin

Study of the QOL Evaluation of Trelagliptin in Patients With Type 2 Diabetes Mellitus

Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)

Efficacy of Ipragliflozin Compared With Sitagliptin in Uncontrolled Type 2 Diabetes With Sulfonylurea and Metformin

Characteristics of Patients With Type 2 Diabetes Mellitus Receiving Treatment With Dapagliflozin Versus Sitagliptin: An Analysis of Commercial Claims and Linked Laboratory Data

Cardiovascular Effects of GLP-1 Receptor Activation

SNP Study of DPP-4 and GLP-1R in Chinese People (Including Diabetes Patients)

A Study of LY3325656 in Healthy Participants and Participants With Type 2 Diabetes

Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

Sitagliptin Improved Beta Cell Function and Prevented a Conversion Rate to Impaired Glucose Tolerance and Type 2 Diabetes in Metformin Intolerant Obese Women With Polycystic Ovary Syndrome

Sitagliptin vs. Pioglitazone as add-on Treatments in Patients With Type 2 Diabetes Uncontrolled on the Full-dose Metformin Plus Sulfonylurea

Therapies on Newly Diagnosed Type 2 Diabetes Patients With High Glucose Toxicity Which Protect Islet β Cell

Empagliflozin Versus Sitagliptin Therapy for Improvement of Myocardial Perfusion Reserve in Diabetic Patients With Coronary Artery Disease

Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort Study

An Efficacy Study of Canagliflozin or Sitagliptin to Determine Glucose Variability in Mexican Participants With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin

Sitagliptin and the Risk for Hypoglycaemia in Type 2 Diabetes Patients

A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease

Effect of Apple Cider Vinegar in Type 2 Diabetics

Effects of a Dipeptidyl Peptidase-4 Inhibitor Sitagliptininsulin on the Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes

A Study to Evaluate the Safety, Tolerability, PK and PD of DA-1241 in Healthy Male Subjects and Subjects With T2DM

Glucagon-like Peptide-1 Levels, Insulin Resistance and Insulin Sensitivity Index in Type 2 Diabetes Mellitus

The Effects of Neprilysin on Glucagon-like Peptide-1

Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1

Drug Interaction Study Between Dorzagliatin and Sitagliptin

Prognostic Predictors of Response to Hypoglycemic Therapy

Approaches To Therapy Escalation In T2D

GA 6: The Blood Glucose-lowering Effect of Glucose-dependent Insulinotropic Polypeptide

Pharmacokinetic Characteristics of GLH1SM Extended Release Tablets in Healthy Volunteers

Effect of Neprilysin on Glucagon-Like Peptide-1 in Patients With Type 2 Diabetes

Gliflozins and Cardiovascular Risk Factors in Type 2 Diabetes (GIOIA)

Pharmacokinetic Characteristics of GLH1SM Extended Release Tablets in Healthy Volunteers(Fed)

Replication of the TECOS Diabetes Trial in Healthcare Claims

Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors and Risk of Cardiovascular Events

Metabolic Responses of Dapagliflozin vs Sitagliptin in T2DM Patients Inadequately Controlled With Insulin Therapy

Safety of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Among Patients With Type 2 Diabetes

A Research Study Comparing a New Medicine Oral Semaglutide to Sitagliptin in People With Type 2 Diabetes

Involvement of Dipeptidyl Peptidase-4 and Sodium-glucose Co-transporter-2 in Extrapancreatic Glucagon Secretion

Study of Real-world Evidence With SGLT2i (Dapagliflozin) and DPP4i (Sitagliptin) in Type 2 Diabetes Patients in Spain

A Study to Evaluate the Efficacy and Safety of DBPR108 100 mg in Type 2 Diabetes Mellitus Patients

Study of Sulphonylurea Synergy With DPP4 Inhibitors

Comparing the Effect of Sitagliptin/Metformin and Metformin in PCOS Patients

Managing DIabetes Remission After Combined Therapy in EarLy Stage of DiabetEs

Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic Agents

A Study Based on Data From German Sick Funds That Looks at the Costs of Treatment of Type-2 Diabetic Patients With Empagliflozin vs. DPP-4 Inhibitors vs. GLP-1 Receptor Agonists

Efficacy of Metformin Versus Sitagliptin on Benign Thyroid Nodules in Type 2 Diabetes

Effects of SGLT2i on the Cognitive Function in T2DM Patient (ESCDP)

Effects of Sitagliptin in Individuals With Genetically Decreased DPP4

The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients

Sitagliptin Treatment in Diabetic COVID-19 Positive Patients

Oral Hypoglycemic Therapy for Monogenic Variant Carriers of the Joslin Medalist Study

Sitagliptin for the Treatment of Grade 3-4 and Refractory Acute Graft-versus-host Disease

Sitagliptin for the Treatment of Type 2 Diabetes

Effect of CPL-2009-0031 in the Treatment of Patients With Uncontrolled Type 2 Diabetes Mellitus

MAGE of Anagliptin Compared With Sitagliptin With Type 2 Diabetes Mellitus

Bioequivalence of Sitagliptin Phosphate/Metformin Hydrochloride Tablets in Healthy Chinese Subjects

Replication of the DAPA-CKD (Chronic Kidney Disease) Trial in Healthcare Claims Data

Safety and Efficacy of Antidiabetic Drugs in Recently Diagnosed Patients With Type 2 Diabetes

IDG-16177 for the Evaluation of Its Safety and Pharmacokinetics

ORAL ANTIDIABETICS EFFECT ON VISCERAL FAT

Comparison of the FGM Profiles in Patients of Type 2 Diabetes Treated With Sitagliptin and Acarbose

Effect of Dapagliflozin vs Sitagliptin on Liver Fat Accumulation and Body Composition in Patients With Diabetes Mellitus and Liver Transplantation

Replication of the GRADE Diabetes Trial in Healthcare Claims Data

Sitagliptin for Prevention of aGVHD After Alternative Donor Transplation

BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes

Monitoring Parameters Beyond Glycemic Control: Impact of Sitagliptin on Quality of Life in Type 2 Diabetes Patients

Semaglutide vs Sitagliptin

A Clinical Study on the Effect of Hypoglycemic Drugs on the Prognosis of Spinal Surgery in Diabetic Patients

Effects of Sitagliptin in Relatives of T1D Patients

Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study

A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers

Phase 1 Bioequivalence Study of Dapagliflozin/Sitagliptin FDC vs Loose Combination of Single Components

Cognitive Protective Effect of Newer Antidiabetic Drugs

The Combination of Sitagliptin and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Which is Better to Start With DPP-4 Inhibitors or SGLT-2 Inhibitors in Egyptian Diabetic Patients?

Canagliflozin and Myocardial Fibrosis

The Effect of Glimepiride Compared With Sitagliptin as an add-on Therapy to Metformin in Severe Insulin Deficiency Diabetes

A Pharmacokinetic Study of DW6012 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers

A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers

Non-alcoholic Fatty Liver Disease and Its Treatment

Comparative Bioavailability Study of Metformin/Sitagliptin 850 mg/50 mg Tablets in Healthy Male and Female Volunteers

Comparative Bioavailability Study of Sitagliptin/Metformin 50 mg/1000 mg Tablets in Healthy Male and Female Volunteers

Combination of Ertugliflozin And Sitagliptin Efficacy, Safety & Tolerability (CEASE Diabetes) Study

SITAgliptin Plus GLARgine to Glycemic Control in the Hospital Setting (SITAGLAR-H)

Sitagliptin in Combination With Beidougen Capsule for Type 2 Diabetes

Perioperative Sitagliptin Medication for Reduction of the Inflammatory Response Associated With Cardiopulmonary Bypass

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors

Bioequivalence Study of of Metformin HCl From Gleptomet 50/1000 mg F.C.Tablets (EVA Pharma, Egypt) and Janumet 50/1000 mg F.C.Tablets (Merck Sharp & Dohme, The Netherlands)

Variable Effects of Anti-diabetics on Stress Hyperglycemia Ratio

Polypill Versus Metformin in New Onset Type 2 Diabetes

Semaglutide and Vascular Regeneration

High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of K-757 in Healthy Overweight/Obese Volunteers

Sitagliptin Combined With Gemcitabine and Albumin-bound Paclitaxel in PDAC Patients

Effect of Sitagliptin on Polycystic Ovarian Syndrome Patients

Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASH

The Impact of Sitagliptin as an Add on Therapy With Closed Loop Control in Adolescents With Diabetic Nephropathy

Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions.

Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.

Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions.

Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.

To Compare the Safety and Efficacy of Dapagliflozin Plus Metformin Versus Sitagliptin Plus Metformin for Treatment of Diabetes in Patients With Compensated and Stable Decompensated Cirrhosis

SGLT Inhibitors Versus DDP4 Inhibitors and Prostate in Patient With Diabetes

Efficay and Safety of Empagliflozin Versus Sitagliptin for the In-patient Management of Hyperglycemia

A Clinical Trial to Evaluate the Food Effect on Pharmacokinetic Profiles and Safety of CKD-379

Sitagliptin and Metformin Hydrochloride Tablets 50 mg/500 mg Relative to Originator

Sitagliptin and Metformin Hydrochloride Tablets 50 mg/1000 mg Relative to Originator

Anti-Diabetic Medications to Fight PD and LBD

Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh

To Compare the Effects of Herbal Medicines With Traditional Allopathic Medicines in Cases of Patients With Metabolic Syndrome

iSGLT2 Inhibitor and a iDPP -4 Inhibitor in Treatment of Type 2 Diabetes Mellitus in Patients Treated With Metformin (TRIAD)

Comparative Analysis of Cost-effectiveness Between Sulfonylureas and DPP4 Inhibitors in Combination With Metformin in Treatment of Type 2 Diabetic Patients : A Retrospective, Observational Study.

Comparative Study of Sitagliptin and Gliclazide With Metformin in Type 2 Diabetes Patients With Glucotoxicity

Emulating the PIONEER6 Diabetes Trial Using Healthcare Claims

Emulation of the SOUL Diabetes Trial in Healthcare Claims

Emulation of the SUSTAIN6 Diabetes Trial Using Healthcare Claims

Glimepiride, Empagliflozin, and Sitagliptin With Metformin for Type 2 Diabetes

DPP4-Inhibitors and Bone Metabolism in Diabetes

Pharmacogenetics of Response to Sitagliptin (PRS)

Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.

Emulation of the STEP-HFpEF DM Heart Failure Trial in Healthcare Claims Data

Emulation of the SUMMIT Heart Failure Trial in Healthcare Claims Data

Effect of Sitagliptin and Empagliflozin in Combination With Metformin on Hs-CRP Levels in Patients With Type 2 Diabetes Mellitus

Comparison Between Efficacy of Trelagliptin and Sitagliptin in Type II Diabetic Patients

Clinical Trial to Evaluate the Efficacy and Safety of DW1026C1 or DW1026C2

The Effect of Sitagliptin, Pioglitazone and Dapagliflozine on Myocardial Infarction in Diabetic Rats

Comparative Effectiveness of Tirzepatide and Semaglutide in Individuals at Cardiovascular Risk

Effect of Add-on SGLT2i, TZD, or Combination Therapy in Type 2 Diabetes Patients on DPP4 Inhibitors

Mangosteen Supplement as Adjuvant Therapy With Sitagliptin/Metformin in Iraqi Patients With Type 2 Diabetes

Using Secondary Data to Evaluate Sex-based Heterogeneity of GLP-1 Agonists and SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic Health (CKMH) Outcomes in Real-world Settings (DASH-CKMH)

Comparative Effectiveness of Tirzepatide Versus Sitagliptin in Individuals at Cardiovascular Risk (TIRZSITA-CVOT)

Evaluate the Efficacy and Safety of Empagliflozin or Glimepiride Combination Therapy in Type 2 Diabetes Mellitus Patients

Comparative Effectiveness of Oral Semaglutide vs Sitagliptin Among Individuals With Heart Failure With Preserved Ejection Fraction (STEP-HFpEF DM ORAL)

INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD)

Emulation of the REWIND Cardiovascular Outcomes Trial in Healthcare Claims Data.

Comparative Study Between (SGLT-2i) and (DPP-4i) in the Prevention of DIC

Dose Optimization of Sitagliptin and Duloxetine in Diabetic Cirrhosis

Metformin, Empagliflozin With Sitagliptin vs Linagliptin in Type 2 Diabetes

Effects of Empagliflozin-Metformin, Sitagliptin-Metformin, and Metformin on Adipokines in Type 2 Diabetes

A Phase 1 Study to Assess the Effect of ABBV-722 on Midazolam, Digoxin, Pitavastatin, Metformin, and Sitagliptin Drug Levels in Healthy Adults.